EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Vancomycin-Resistant E. faecium: Addressing Global and Clinical Challenges

Daniel E Radford-Smith iD, Daniel C Anthony iD

Antibiotics · 19.05.2025 · 14 (5) · 522

DOI: 10.3390/antibiotics14050522 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antibiotics, online erschienen am 19.05.2025. Verfasst von Daniel E Radford-Smith und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of Oxford, Oxford OX1 3QT, UK. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial resistance (AMR) poses a profound threat to modern healthcare, with vancomycin-resistant Enterococcus faecium (VREfm) emerging as a particularly resilient and clinically significant pathogen. This mini-review examines the biological mechanisms underpinning VREfm resistance, including biofilm formation, stress tolerance, and the acquisition of resistance genes such as vanA and vanB. It also explores the behavioural, social, and healthcare system factors that facilitate VREfm transmission, highlighting disparities in burden across vulnerable populations and low-resource settings. Prevention strategies are mapped across the disease pathway, spanning primary, secondary, and tertiary levels, with a particular focus on the role and evolving challenges of antimicrobial stewardship programmes (ASP). We highlight emerging threats, such as rifaximin-induced cross-resistance to daptomycin, which challenge conventional stewardship paradigms. Finally, we propose future directions to enhance global surveillance, promote equitable stewardship interventions, and accelerate the development of innovative therapies. Addressing VREfm requires a coordinated, multidisciplinary effort to safeguard the efficacy of existing antimicrobials and protect at-risk patient populations.

Schlagwörter

Stichwörter der Autor:innen

antimicrobial resistanceantimicrobial stewardshipvancomycin-resistant Enterococcus faecium

Autor:innen und Institutionen

  • Department of Pharmacology, University of Oxford, Oxford OX1 3QT, UK.

ORCID-Profile: Daniel E Radford-Smith, Daniel C Anthony

Zitieren

APA

Radford-Smith, D. E., & Anthony, D. C. (2025). Vancomycin-Resistant E. faecium: Addressing Global and Clinical Challenges. Antibiotics, 14(5), 522. https://doi.org/10.3390/antibiotics14050522

Vancouver

Radford-Smith DE, Anthony DC. Vancomycin-Resistant E. faecium: Addressing Global and Clinical Challenges. Antibiotics. 2025;14(5):522. doi:10.3390/antibiotics14050522

BibTeX
@article{RadfordSmith2025,
  author = {Radford-Smith, Daniel E and Anthony, Daniel C},
  title = {Vancomycin-Resistant E. faecium: Addressing Global and Clinical Challenges},
  journal = {Antibiotics},
  year = {2025},
  volume = {14},
  number = {5},
  pages = {522},
  doi = {10.3390/antibiotics14050522}
}
Kostenlos starten →